Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Trial
- 22 October 2002
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (17) , 2164-2166
- https://doi.org/10.1161/01.cir.0000038702.35084.d6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart FailureCirculation, 2002
- A Trial of the Beta-Blocker Bucindolol in Patients with Advanced Chronic Heart FailureNew England Journal of Medicine, 2001
- Effect of Carvedilol on Survival in Severe Chronic Heart FailureNew England Journal of Medicine, 2001
- Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costsJournal of the American College of Cardiology, 2001
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Beneficial effects of metoprolol in idiopathic dilated cardiomyopathyThe Lancet, 1993
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Xamoterol in severe heart failureThe Lancet, 1990